Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 1.9e-05 | 1 |